Monday, Nov 11 12:30 - 1:30 pm

Nosocomial Pneumonia – Burden of Disease and Therapeutic Landscape - Merck Lunch Symposium

Sponsored by:

Objectives:

  1. What is known in 2019 about the epidemiology and progression of ventilated Nosocomial Pneumonia (NP) – Epidemiology and Burden of Disease
  2. Treatment of Nosocomial Pneumonia and Current Guidelines
  3. Overview of Novel Therapeutics for Nosocomial Pneumonia and their place in the ID clinical setting

Speaker: Dr. Anand Kumar

Tuesday, Nov 12 6:30 – 7:45 am

Procalcitonin in a Canadian Intensive Care Unit: Lessons Learned - Thermo Fisher Breakfast Symposium

Sponsored by:

B·R·A·H·M·S PCT (Procalcitonin) has been recommended as a biomarker to guide antibiotic de-escalation in several international critical care guidelines, but to date there has been little reported on its use in Canada. This talk will review the science behind how PCT works as a biomarker for bacterial infections and the evidence for its use in PCT-guided antibiotic stewardship. The experience from our pilot study at Saint Joseph’s Health Centre in Toronto will be shared, focusing on lessons learned and PCT’s utility in the ICU clinical setting.

Objectives:

  1. Review the science behind how procalcitonin works as a biomarker
  2. Review the evidence for procalcitonin use in identifying bacterial infections, focusing primarily on the critical care setting
  3. Share the experience from the pilot study at Saint Joseph’s Health Centre in Toronto

SpeakerMark Downing, MD

Tuesday, Nov 12 12:30 – 1:30 pm

Differentiating TMA Syndromes in the Critical Care Patient - Alexion Lunch Symposium

Sponsored by:

Objectives:

  1. Review an illustrative thrombotic microangiopathy (TMA )case in the Critical Care setting
  2. Recognize the findings that suggest the presence of TMA
  3. Discuss TMA diagnostic work-up and management
  4. Review TMA complications a Critical Care patient might develop

SpeakerJocelyn Garland, MD